Hybio Pharmaceutical (300199) — Financial Flexibility Index
Hybio Pharmaceutical (300199) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of CN¥213.38 Million (operating CF CN¥117.78 Million minus capex CN¥95.60 Million) represents 0% of total liabilities (CN¥2.50 Billion). Check Hybio Pharmaceutical total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hybio Pharmaceutical Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Hybio Pharmaceutical across 18 annual periods. For the full cash flow conversion analysis, see 300199 cash flow metrics.
Annual Financial Flexibility Index for Hybio Pharmaceutical (2007–2024)
Year-by-year free cash flow to debt coverage for Hybio Pharmaceutical. Explore 300199 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | CN¥280.54 Million | CN¥164.71 Million | CN¥2.41 Billion | ▲ +270.9% |
| 2023 | 0.03x | CN¥78.23 Million | CN¥-3.54 Million | CN¥2.49 Billion | ▼ -64.7% |
| 2022 | 0.09x | CN¥205.65 Million | CN¥15.81 Million | CN¥2.31 Billion | ▼ -43.6% |
| 2021 | 0.16x | CN¥355.83 Million | CN¥156.83 Million | CN¥2.26 Billion | ▲ +26.5% |
| 2020 | 0.12x | CN¥291.65 Million | CN¥47.99 Million | CN¥2.34 Billion | ▼ -54.0% |
| 2019 | 0.27x | CN¥674.79 Million | CN¥104.64 Million | CN¥2.49 Billion | ▲ +48.9% |
| 2018 | 0.18x | CN¥412.57 Million | CN¥47.00 Million | CN¥2.27 Billion | ▼ -40.9% |
| 2017 | 0.31x | CN¥434.88 Million | CN¥213.74 Million | CN¥1.41 Billion | ▼ -36.4% |
| 2016 | 0.48x | CN¥412.46 Million | CN¥296.41 Million | CN¥852.42 Million | ▼ -11.7% |
| 2015 | 0.55x | CN¥497.82 Million | CN¥138.84 Million | CN¥908.68 Million | ▼ -7.8% |
| 2014 | 0.59x | CN¥238.59 Million | CN¥153.43 Million | CN¥401.32 Million | ▼ -78.6% |
| 2013 | 2.77x | CN¥456.33 Million | CN¥153.48 Million | CN¥164.48 Million | ▼ -3.4% |
| 2012 | 2.87x | CN¥308.57 Million | CN¥87.19 Million | CN¥107.42 Million | ▲ +13.5% |
| 2011 | 2.53x | CN¥150.74 Million | CN¥72.48 Million | CN¥59.56 Million | ▲ +5.5% |
| 2010 | 2.40x | CN¥77.52 Million | CN¥54.69 Million | CN¥32.30 Million | ▲ +274.1% |
| 2009 | 0.64x | CN¥35.11 Million | CN¥26.11 Million | CN¥54.73 Million | ▼ -77.4% |
| 2008 | 2.84x | CN¥106.02 Million | CN¥45.75 Million | CN¥37.32 Million | ▼ -49.7% |
| 2007 | 5.65x | CN¥53.93 Million | CN¥49.04 Million | CN¥9.54 Million | — |